Hosted on MSN7mon
EMA CHMP recommends Novo Nordisk’s weekly insulin for diabetes
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Novo Nordisk's Awiqli, a once-weekly basal insulin icodec, for ...
pharmaphorum4d
FDA rejects Novo Nordisk’s weekly basal insulin
Awiqli has been cleared for both types of diabetes in all its current markets except China, where it can be used for type 2 only. “We believe in the potential of once-weekly basal insulin icodec ...
FiercePharma15d
Novo Nordisk hit with FDA write-up over production issues at critical semaglutide plant
Novo's spokesperson said the issues around the insulin product—approved in places like Canada, Europe and Japan as Awiqli—are unlikely to be resolved this year. Fire breaks out at Novo ...
Yahoo Finance1mon
NVO Stock Loses Around $29B in 3 Months: Buy the Dip or Steer Clear?
Image Source: Zacks Investment Research The dip in the stock price was primarily observed after the company faced a major setback in July when the FDA rejected its regulatory filing seeking approval ...